Male Breast Carcinoma Active Not Recruiting Phase 3 Trials for Ixabepilone (DB04845)

IndicationStatusPhase
DBCOND0030384 (Male Breast Carcinoma)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00785291Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast CancerTreatment